Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0778
-0.0002 (-0.21%)
Sep 8, 2025, 11:27 AM EDT
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $6.84 million as of September 8, 2025. Its market cap has decreased by -61.55% in one year.
Market Cap
6.84M
Enterprise Value
8.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 6.84M, a decrease of -73.19%. That is a compound annual growth rate of -17.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 6.94M | -11.03% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | 23.39M | -4.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |